Lymphoproliferative disorders in renal transplant patients in Japan
- 23 January 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 91 (6) , 869-875
- https://doi.org/10.1002/1097-0215(200002)9999:9999<::aid-ijc1125>3.0.co;2-n
Abstract
Post‐transplantation lymphoproliferative disorders (PT‐LPD) are characterized by a clinically and morphologically heterogeneous group of lymphoid proliferation occurring after organ or bone marrow transplantation. The immunodeficient state provides a basis for lymphomagenesis probably through activation of oncogenic viruses. Twenty‐four patients in whom PT‐LPD developed after renal transplantation in Japan were analyzed. They received hemodialysis for 4 to 226 (median 13) months before transplantation. In situ hybridization was performed to detect Epstein‐Barr virus (EBV). Polymerase chain reaction and Southern hybridization with primers in the tax and pol regions of human T‐cell leukemia virus type I (HTLV‐1) were performed on DNA extracted from paraffin‐embedded specimens. Immunohistochemical analysis revealed that 12 cases were B‐cell type, 10 cases (42%) T‐cell type and 2 NK‐cell type. Five of the T‐cell cases were classified as adult T‐cell lymphoma with proven HTLV‐1 genome in the tumor and seropositivity for the virus. These cases were classified as adult T‐cell lymphoma (ALT). More than 80% of B‐cell, 30% of T‐cell and both NK/T‐cell lymphomas were EBV‐positive. Co‐infection of EBV and HTLV‐1 was found in 2 cases with ATL. These findings showed that ATL is common among Japanese renal transplant patients, which might be due to transmission of HTLV‐1 via blood transfusion during hemodialysis.Keywords
This publication has 31 references indexed in Scilit:
- Epstein–Barr Virus and a Cellular Signaling Pathway in Lymphomas from Immunosuppressed PatientsNew England Journal of Medicine, 1998
- Epstein‐Barr Virus‐Induced T Cell Lymphoma in Solid Organ Transplant RecipientsClinical Infectious Diseases, 1998
- Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.Proceedings of the National Academy of Sciences, 1992
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.The Journal of Experimental Medicine, 1992
- AIDS-associated non-Hodgkin lymphomaThe Lancet, 1991
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989
- Statistical Analyses of Clinico-Pathological, Virological and Epidemiological Data on Lymphoid Malignancies with Special Reference to Adult T-Cell Leukemia/Lymphoma: A Report of the Second Nationwide Study of JapanJapanese Journal of Clinical Oncology, 1985
- Epstein-Barr Virus (EBV) Induced Polyclonal and Monoclonal B-Cell Lymphoproliferative Diseases Occurring after Renal TransplantationAnnals of Surgery, 1983
- Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.Proceedings of the National Academy of Sciences, 1982
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980